These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39419065)

  • 1. Biological effectiveness of uniform and nonuniform dose distributions in radiotherapy for tumors with intermediate oxygen levels.
    Chvetsov AV; Pugachev A
    Biomed Phys Eng Express; 2024 Oct; 10(6):. PubMed ID: 39419065
    [No Abstract]   [Full Text] [Related]  

  • 2. Equivalent uniform aerobic dose in radiotherapy for hypoxic tumors.
    Chvetsov AV; Muzi M
    Phys Med Biol; 2024 Apr; 69(8):. PubMed ID: 38457839
    [No Abstract]   [Full Text] [Related]  

  • 3. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
    Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
    Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volume dependence in hypoxia-targeted dose escalation.
    Chvetsov AV; Zeng J; Rajendran JG
    Med Phys; 2018 Nov; 45(11):5325-5331. PubMed ID: 30192391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume effects in the TCP for hypoxic and oxygenated tumors.
    Chvetsov AV; Stewart RD; Kim M; Meyer J; Rengan R
    Med Phys; 2020 Sep; 47(9):4626-4633. PubMed ID: 32452034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.
    Carlson DJ; Stewart RD; Semenenko VA
    Med Phys; 2006 Sep; 33(9):3105-15. PubMed ID: 17022202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer.
    Köthe A; Bizzocchi N; Safai S; Lomax AJ; Weber DC; Fattori G
    Radiat Oncol; 2021 Oct; 16(1):199. PubMed ID: 34635135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
    Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
    Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation.
    Kjellsson Lindblom E; Ureba A; Dasu A; Wersäll P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I
    Med Phys; 2019 May; 46(5):2512-2521. PubMed ID: 30924937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia.
    Ruggieri R
    Phys Med Biol; 2004 Oct; 49(20):4811-23. PubMed ID: 15566177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes.
    Antonovic L; Lindblom E; Dasu A; Bassler N; Furusawa Y; Toma-Dasu I
    J Radiat Res; 2014 Sep; 55(5):902-11. PubMed ID: 24728013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radiobiological model of reoxygenation and fractionation effects.
    Guerrero M; Carlson DJ
    Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of equivalent uniform dose using the L-curve criterion.
    Chvetsov AV; Dempsey JF; Palta JR
    Phys Med Biol; 2007 Oct; 52(19):5973-84. PubMed ID: 17881813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor control probability in hypofractionated radiotherapy as a function of total and hypoxic tumor volumes.
    Chvetsov AV; Hanin LG; Stewart RD; Zeng J; Rengan R; Lo SS
    Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34030139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
    Lindblom E; Dasu A; Toma-Dasu I
    Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalent uniform RBE-weighted dose in eye plaque brachytherapy.
    Chvetsov AV
    Med Phys; 2024 Apr; 51(4):3093-3100. PubMed ID: 38353266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.
    Wenzl T; Wilkens JJ
    Radiat Oncol; 2011 Dec; 6():171. PubMed ID: 22172079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.
    Ruggieri R; Nahum AE
    Med Phys; 2006 Nov; 33(11):4044-55. PubMed ID: 17153384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A theoretical cell-killing model to evaluate oxygen enhancement ratios at DNA damage and cell survival endpoints in radiation therapy.
    Matsuya Y; Sato T; Nakamura R; Naijo S; Date H
    Phys Med Biol; 2020 Apr; 65(9):095006. PubMed ID: 32135526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
    Chan MKH; Chiang CL
    Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.